Nicholas Investment Partners, LP
Position in VERA — Vera Therapeutics, Inc.
CIK 1389574
RANCHO SANTA FE, CA
Position in VERA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,859,344
-$3,473,834 QoQ
Shares Held
95,932
-33.8% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nicholas Investment Partners, LP holds $271,971,066 across 20 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
244,594 | $45,807,564 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
98,974 | $24,225,865 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
395,844 | $23,893,143 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
311,494 | $23,200,073 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
172,695 | $20,217,403 | |
| 6 | ELVN |
Enliven Therapeutics, Inc.
|
391,529 | $19,870,096 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
186,769 | $18,206,242 | |
| 8 | CYTK |
Cytokinetics Inc
|
209,071 | $17,810,758 |
All Filings in VERA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,859,344 | 95,932 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,333,178 | 144,810 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $2,291,556 | 95,402 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,516,783 | 106,805 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,162,907 | 71,559 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,139,287 | 59,129 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||